Oncology & Cancer

Fat-secreted molecule lowers response to common cancer treatment

Leptin, a molecule produced by fat cells, appears to cancel out the effects of the estrogen-blocking therapy tamoxifen, a drug commonly used to treat and prevent breast cancers, suggests a new study led by researchers from ...

Overweight & Obesity

Age is no barrier to successful weight loss, new study finds

Obese patients over the age of 60 can lose an equivalent amount of weight as younger people using only lifestyle changes, according to a new study from the University of Warwick and University Hospitals Coventry and Warwickshire ...

Neuroscience

New stroke treatments becoming a reality

Scientists led by the President of The University of Manchester have demonstrated a drug which can dramatically limit the amount of brain damage in stroke patients.

Oncology & Cancer

A potential new marker for personalized breast cancer therapy

A new study from the University of Southampton has discovered that "crown-like structures" surrounding breast tumors in overweight and obese patients could hinder their response to therapy. The findings of this study could ...

Surgery

Weight-loss surgery cuts heart risk 7 years later: study

(HealthDay) -- Seven years after they underwent weight-loss surgery, patients as a whole fared better on several measurements of their risk of cardiac problems, a new study finds, and many returned to normal levels.

Medications

Ivermectin, luvox fail as COVID-19 treatments

Two drugs touted as potential COVID-19 treatments, ivermectin and fluvoxamine, don't do a thing to improve patients' oxygen levels and keep them out of the hospital or the morgue, a new clinical trial has shown.

page 13 from 40